If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

17 Oct 2007 10:25

British Smaller Companies VCT PLC17 October 2007 17 October 2007 BRITISH SMALLER COMPANIES VCT PLC Unaudited half year statements for the 6 months to 30 September 2007 British Smaller Companies VCT plc ("the Company") today announces its unauditedhalf year results for the six months to 30 September 2007. Chairman's Statement I am pleased to present the half year results which reflect a very active sixmonths both for new investments, our own fundraising and the portfolio, whichhas resulted in a period of continued growth in net asset value. For the sixmonths to 30 September 2007, net asset value, before taking account of theinterim dividend, has risen to 102.7 pence per Ordinary share an increase of 4.2pence per over the same period last year. This has increased total return to140.7 pence per share an increase of 6.5% over the same period last year. In December 2006 the Company launched its share offers which were successfullyclosed during April 2007 raising a total of £9.2 million after expenses. Sincethose share offers opened, the Company has invested a total of £3.9 million in 6companies, of which £2.7 million has been invested in the six months to 30September 2007. As a consequence of this continued performance, I am pleased to announce thatthe interim dividend will be 2 pence per share, an increase of 33% over theprevious year. The dividend will be paid on 16 November 2007 to shareholders onthe register at 26 October 2007. Interim Management Report During the period the directors consider the following events to have been ofparticular importance. Important Events in the Period The first six months of this financial year has seen two investments realisedfor a total of £1.36 million compared to a cost of £0.44 million. Theseinvestments were Oasis Healthcare plc (a nationwide chain of dentalpractitioners - which realised a profit of £0.66 million) and JDA Limited (anorth of England based advertising and marketing agency - which realised aprofit of £0.26 million). In addition, on 28 September 2007 at an EGM of Cozart plc its shareholders votedto accept an offer of 57.5 pence per share from Concateno plc. The value of thisoffer to this Company is £2.2 million. Cozart plc became an investment in 2001when it was a small unquoted company. Cozart achieved its listing on theAlternative Investment Market (AIM) in 2004 at a price of 30 pence per share.The offer for Cozart plc values the company at £64 million. Your company'sresidual holding in Cozart plc was acquired at a cost of £0.45 million. This first six months of the year has also seen high levels of activity in newinvestment. In total, £2.7 million has been invested of which £2.28 million hasbeen into three unquoted companies and £0.42 million into one AIM listedcompany. The unquoted investments comprised £0.78 million into London-based Harvey JonesLimited (a management buy-out of a kitchen manufacturer and retailer); £0.6million into Kingston-Upon-Thames-based Harris Hill Limited (a management buy-inled by a previous Chief Executive of Office Angels Limited of a businessspecialising in recruitment for the not-for-profit and charity sectors); £0.9million into Goole-based RMS Group Holdings Limited (a buy-in management buy-outof a Humber port operator and stevedoring business). It is also pleasing to note that following the sale of Tamesis Limited toPatsystems plc in 2005 that Tamesis Limited has achieved its earnout conditionsand that consequently the Company has received shares in Patsystems plc to thevalue of £0.2 million. Richard Last, a director of the Company is also adirector and shareholder of Patsystems plc. Financial Results and Dividend The net asset value of the Ordinary shares at 30 September 2007, before takingaccount of the approved interim dividend of 2 pence per share, is 102.7 penceper share. Taking account of the dividends paid to date, the total return foreligible founder shareholders at the balance sheet date is 140.7 pence pershare. The increase in income has arisen largely as a result of the successfulfundraising. This increase has more than offset the rise in the investmentadvisory fee which is linked directly to movements in net asset value. The recorded pre-tax profit for Ordinary shares for the six months ended 30September 2007 is £1.89 million after taking account of realised valuation gainsof £0.64 million and unrealised valuation gains of £1.16 million. Shareholder Relations and Fundraising Following the success of the previous Offers, and taking account of the qualityand number of investment opportunities available, your Board has decided torecommend a further Issue of Ordinary shares. Your Board will be seeking toraise up to £5 million. A further fundraising will allow your Company to takeadvantage of the increasing proprietary investment flow arising from thenational office network of YFM Private Equity and to benefit further fromincreasing the scale of your Company. Details of the Offer will be sent toshareholders in the near future. The Company continues to operate a share buy back policy to enable shareholdersto obtain some liquidity in what remains a relatively illiquid market wherethere is a need to dispose of their stock. This policy is kept under review toensure that any decisions taken are in the best interests of shareholders as awhole. In accordance with this policy, the Company has purchased a total of448,445 shares during the period at an average price of 86.81 pence per shareand the shares have been placed in Treasury. These purchases are made with fundstaken from the Special Reserve and do not adversely impact on the Company'sability to distribute tax free dividends to shareholders. Your Company continues to undertake workshops where shareholders are invited tomeet members of the Board and the Investment Adviser and have the opportunity tomeet some of the management teams of your Company's investments. It is intendedto hold the next workshop in February 2008. Outlook and Risks The directors believe that the principal risks and uncertainties facing theCompany for the remaining six months of the year continue to be theidentification of sufficient quality of new investment opportunities. Generalmarket conditions have provided a more volatile backdrop with some continueduncertainty over the attitude that banks will take to providing debt in supportof private equity and venture capital transactions. To date there has been noevidence of any material change to the market in which venture capital trustsoperate, but the Board will continue to keep the situation under close review.It also remains unclear as to what effect the recently announced changes inrespect of moving to a single rate of capital gains tax of 18% will have onprivate investors and entrepreneurs both in the unquoted and AIM markets. Againthe Board continues to keep this developing situation under close review. Inaddition, market and liquidity risks are greater for unquoted and AIM tradedcompanies than investment in companies traded on the main market. The Board willcontinue to seek to mitigate these risks by setting policies, reviewingperformance and monitoring progress. The recent economic climate has supported a strong corporate market enablingyour Company to continue its record of successful realisations supporting theincrease in dividend policy. The underlying performance of the remainder of theportfolio continues to show pleasing progress and it is a feature of theportfolio that it is not exposed to significant levels of debt finance. Thisinvestment structure has been continued through to the new investments whereyour Company has sought to ensure that, as a portfolio, the exposure to debtlevels is not significantly increased. Your Company remains well positioned totake advantage of selective investment opportunities as they arise and yourBoard remains optimistic about the second half of the year. Sir Andrew Hugh Smith17 October 2007 Income StatementFor the 6 months ended 30 September 2007 Unaudited Unaudited Audited 6 months ended 6 months ended Year ended 30 September 30 September 31 March 2007 2006 2007 Notes £000 £000 £000 Income 489 215 368 Administrative expenses:Investment advisory fee (299) (186) (381)Other expenses (106) (131) (234) --------- --------- --------- (405) (317) (615) Operating profit (loss) 84 (102) (247) --------- --------- ---------Gains on realisation of investments (net) 642 194 503 Unrealised gains on investments held at fair value (net) 1,162 493 1,082 --------- --------- ---------Net movement on investments 1,804 687 1,585 --------- --------- ---------Profit on ordinary activities before taxation 1,888 585 1,338 Taxation 2 - - - --------- --------- ---------Profit for the periodfrom continuing operations 1,888 585 1,338 --------- --------- ---------Basic and dilutedearnings per share 4 7.37p 3.43p 7.91p --------- --------- --------- Balance SheetAs at 30 September 2007 Unaudited Unaudited Audited 6 months ended 6 months ended Year ended 30 September 30 September 31 March 2007 2006 2007 Notes £000 £000 £000 Assets Non-current assets Financial assets at fairvalue through profit or loss 14,699 10,262 11,627 --------- --------- ---------Current assetsTrade and other receivables 631 506 512Cash and cash equivalents 11,504 5,991 4,867 --------- --------- --------- 12,135 6,497 5,379Liabilities Current liabilitiesTrade and other payables (155) (103) (218) --------- --------- ---------Net current assets 11,980 6,394 5,161 --------- --------- ---------Net assets 26,679 16,656 16,788 --------- --------- ---------Shareholders' equityShare capital 2,641 2,191 2,148Share premium account 10,504 1,813 1,813Capital redemption reserve 221 178 221Special reserve 2,019 2,795 2,408Retained earnings 11,294 9,679 10,198 --------- --------- ---------Total Shareholders' equity 26,679 16,656 16,788 --------- --------- ---------Net asset value per Ordinary share 5 102.7p 98.5p 101.3p --------- --------- ---------Net asset value per C share 5 n/a* 101.5p 110.8p --------- --------- --------- * The C shares were converted into Ordinary shares on 9 May 2007. Unaudited Statement of Changes in Shareholders' EquityFor the 6 months ended 30 September 2007 Share Share Capital Special Retained Total capital premium redemption reserve earnings equity account reserve £000 £000 £000 £000 £000 £000 Balance at 31 March 2006 2,195 1,336 117 3,330 9,569 16,547Purchase of own shares (61) - 61 (535) - (535)Issue of Ordinary shares 57 477 - - - 534Dividends - - - - (475) (475)Profit for the period - - - - 585 585 --------- ------- -------- ------- -------- --------Balance at 30 September 2006 2,191 1,813 178 2,795 9,679 16,656Purchase of own shares (43) - 43 (387) - (387)Dividends - - - - (234) (234)Profit for the period - - - - 753 753 --------- ------- -------- ------- -------- --------Balance at 31 March 2007 2,148 1,813 221 2,408 10,198 16,788Issue of Ordinary shares 980 8,723 - - - 9,703Issue costs - (444) - - - (444)C share conversion (487) 493 - - - 6Commissions paid - (81) - - - (81)Purchase of own shares - - - (389) - (389)Dividends - - - - (792) (792)Profit for the period - - - - 1,888 1,888 --------- ------- -------- ------- -------- --------Balance at 30 September 2007 2,641 10,504 221 2,019 11,294 26,679 --------- ------- -------- ------- -------- -------- Unaudited Cash Flow StatementFor the 6 months ended 30 September 2007 Unaudited Unaudited Audited 6 months ended 6 months ended Year ended 30 September 30 September 31 March 2007 2006 2007 £000 £000 £000 Net cash outflow from operating activities (182) (93) (267) --------- --------- --------- Cash flows (used in) from investing activities Purchase of fixed asset investments (2,705) - (1,380)Proceeds from sale of fixedasset investments 1,605 1,230 2,198 --------- --------- ---------Net cash (used in) frominvesting activities (1,100) 1,230 818 --------- --------- --------- Cash flows from (used in)financing activities Cost of C share issue - (2) (3)Issue of Ordinary shares 9,703 564 574Cost of Ordinary share issue (520) (70) (80)Purchase of own Ordinary shares (515) (535) (796) Dividends paid (792) (475) (709) --------- --------- ---------Net cash from (used in)financing activities 7,876 (518) (1,014) --------- --------- ---------Net increase (decrease) incash and cash equivalents 6,594 619 (463) Cash and cash equivalentsat the beginning of the period 4,867 5,395 5,395 Effect of market valuechanges in cash equivalents 43 (23) (65) --------- --------- ---------Cash and cash equivalentsat the end of the period 11,504 5,991 4,867 --------- --------- --------- Notes to the Financial StatementsFor the 6 months ended 30 September 2007 1. These half year statements, which have been approved by the directors whose names appear at note 6, each of whom has confirmed that to the best of his knowledge the Interim Management Report includes a fair review of the information required by Rules 4.2.7 and 4.2.8 of the Disclosure Rules and the Transparency Rules. The half year statements are unaudited, nor have they been reviewed by theauditors pursuant to the Auditing Practices Board (ASB) guidance on Review ofInterim Financial Information. They do not constitute full financial statementsas defined in section 240 of the Companies Act 1985. The comparative figures forthe year ended 31 March 2007 do not constitute full financial statements andhave been extracted from the Company's financial statements for the year ended31 March 2007. Those accounts were reported upon without qualification by theauditors and have been delivered to the Registrar of Companies. The half year statements comply with IAS 34 'Interim financial reporting' andthe accounting policies and methods of computation followed in the half yearstatements are the same as those adopted in the preparation of the auditedfinancial statements for the year ended 31 March 2007. The financial statements for the year ended 31 March 2007 were prepared inaccordance with the International Financial Reporting Standards (IFRS), whichcomprise standards and interpretations approved by the International AccountingStandards Board (IASB) and the International Accounting Standards Committee(IASC) as adopted by the European Union and those parts of the Companies Act1985 applicable to companies reporting under IFRS. 2. Taxation charge: Unaudited Unaudited Audited 6 months ended 6 months ended Year ended 30 September 30 September 31 March 2007 2006 2007 £000 £000 £000Profit on ordinary activities multiplied bystandard small company rate of corporation tax in the UK of 19% (2006: 19%) 359 111 254 Effect of:UK dividends received (13) (16) (21)Non taxable profits on investments 3) (130) (301)Excess management expenses (3) 35 68 --------- --------- ---------Current tax charge for the period - - - --------- --------- --------- The Company has no provided, or unprovided, deferred tax liability in eitheryear. Deferred tax assets in respect of losses have not been recognised as managementcurrently believe that there will not be sufficient taxable profits againstwhich the assets can be recovered. Due to the Company's status as a venture capital trust, and the continuedintention to meet the conditions required to comply with Chapter 3 of Part 6 ofthe Income Tax Act 2007, the Company has not provided deferred tax on anycapital gains or losses arising on the revaluation or realisation ofinvestments. 3. Dividends Unaudited Unaudited Audited 6 months ended 6 months ended Year ended 30 September 30 September 31 March 2007 2006 2007 £000 £000 £000Interim paid - 1.5p per Ordinary share; paid 6 November 2006 - - 234 Final paid - 3.0p per Ordinary share; paid 11 August 2006 - 469 469 Final paid - 0.5p per C share; paid 11 August 2006 - 6 6 Final paid - 3.0p per Ordinary share; paid 8 August 2007 792 - - --------- --------- ---------Dividends paid and declared 792 475 709 --------- --------- --------- 4. The earnings per share is based on the net profit from ordinary activities after tax attributable to shareholders of £1,888,000 (30 September 2006: £585,000 and 31 March 2007: £1,338,000) and on 25,608,000 shares (30 September 2006: 17,051,000 and 31 March 2007: 16,923,000), being the weighted average number of shares in issue during the period. 448,445 treasury shares have been excluded in calculating the number of Ordinaryshares in issue at 30 September 2007 (30 September 2006 and 31 March 2007: nil).The Company has no securities that would have a dilutive effect and hence basicand diluted earnings per share are the same. 5. The net asset value per share is calculated on attributable assets of £26,679,000 and 25,975,718 shares in issue at the period end (30 September 2006: assets of £16,656,000 and 16,880,040 shares, 31 March 2007: assets of £16,788,000 and 16,450,040 shares). 448,445 treasury shares have been excluded in calculating the number of Ordinaryshares in issue at 30 September 2007 (30 September 2006 and 31 March 2007: nil).The Company has no securities that would have a dilutive effect and hence basicand diluted net asset values per share are the same. 6. The directors of the Company are: Sir Andrew Hugh Smith; Mr PS Cammerman; MrS Noar; Mr RM Pettigrew and Mr R Last. For further information, please contact: David Hall, YFM Private Equity Limited Tel: 0161 819 3195Jonathan Becher, Landesbanki Securities (UK) Limited Tel: 0207 426 3269Michael Bellamy, Landesbanki Securities (UK) Limited Tel: 0207 426 9547 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Apr 20247:58 amRNSIssue of Equity and Close of Offers
26th Mar 202411:11 amRNSTransaction in Own Shares and Total Voting Rights
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNS3rd Quarter Results
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:23 amRNSIssue of Equity
18th Dec 20234:02 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
8th Dec 20239:47 amRNSPayment of Dividend and Issue of Equity
24th Nov 20237:00 amRNSHalf-year Report
26th Oct 20231:34 pmRNSDividend Declaration
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:20 amRNSTransaction in Own Shares and PDMR
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
14th Sep 202310:28 amRNSResult of AGM
14th Sep 202310:28 amRNSResult of General Meeting
13th Sep 20237:00 amRNS1st Quarter Results
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
28th Jul 202310:00 amRNSDirector/PDMR Shareholding
28th Jul 202310:00 amRNSPayment of Dividend and Issue of Equity
27th Jun 20237:45 amRNSTransaction in Own Shares
21st Jun 20231:00 pmRNSPublication of Circular
16th Jun 202312:00 pmRNSAnnual Financial Report
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:23 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:42 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNS3rd Quarter Results
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSDirector/PDMR Shareholding
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:48 amRNSTransaction in Own Shares
6th Dec 20229:58 amRNSOffer Update
6th Dec 20229:58 amRNSOffer Update
30th Nov 202212:30 pmRNSPublication of a Prospectus
30th Nov 202212:30 pmRNSPublication of a Prospectus
25th Nov 20229:30 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.